Vontobel Holding Ltd. Biomarin Pharmaceutical Inc Transaction History

Vontobel Holding Ltd.

  • $29.2 Billion
  • Q3 2024

A detailed history of Vontobel Holding Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Vontobel Holding Ltd. holds 6,050 shares of BMRN stock, worth $403,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,050
Previous 3,497 73.01%
Holding current value
$403,111
Previous $287,000 48.08%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
BUY
$69.02 - $93.84 $176,208 - $239,573
2,553 Added 73.01%
6,050 $425,000
Q2 2024

Aug 13, 2024
SELL
$74.43 - $92.22 $33,493 - $41,499
-450 Reduced 11.4%
3,497 $287,000
Q1 2024

May 10, 2024
SELL
$83.81 - $99.0 $224,610 - $265,320
-2,680 Reduced 40.44%
3,947 $344,000
Q4 2023

Jun 03, 2024
SELL
$76.22 - $98.51 $76,601 - $99,002
-1,005 Reduced 19.83%
4,063 $391,000
Q4 2023

Jan 29, 2024
SELL
$76.22 - $98.51 $97,256 - $125,698
-1,276 Reduced 16.15%
6,627 $638,000
Q3 2023

Jun 03, 2024
SELL
$85.07 - $94.48 $162,909 - $180,929
-1,915 Reduced 27.42%
5,068 $448,000
Q3 2023

Oct 10, 2023
SELL
$85.07 - $94.48 $162,909 - $180,929
-1,915 Reduced 19.5%
7,903 $699,000
Q2 2023

Jun 03, 2024
BUY
$86.68 - $100.3 $92,314 - $106,819
1,065 Added 18.0%
6,983 $605,000
Q2 2023

Jul 24, 2023
BUY
$86.68 - $100.3 $92,314 - $106,819
1,065 Added 12.17%
9,818 $851,000
Q1 2023

Jun 03, 2024
BUY
$87.74 - $117.27 $172,935 - $231,139
1,971 Added 49.94%
5,918 $575,000
Q1 2023

Apr 12, 2023
BUY
$87.74 - $117.27 $281,996 - $376,905
3,214 Added 58.02%
8,753 $851,000
Q4 2022

Feb 14, 2023
BUY
$80.93 - $108.63 $50,419 - $67,676
623 Added 12.67%
5,539 $573,000
Q3 2022

Nov 04, 2022
SELL
$82.16 - $96.94 $128,251 - $151,323
-1,561 Reduced 24.1%
4,916 $418,000
Q2 2022

Jul 27, 2022
SELL
$71.48 - $86.85 $53,895 - $65,484
-754 Reduced 10.43%
6,477 $544,000
Q1 2022

May 13, 2022
SELL
$74.28 - $92.69 $79,925 - $99,734
-1,076 Reduced 12.95%
7,231 $563,000
Q4 2021

Feb 14, 2022
BUY
$71.72 - $91.47 $53,503 - $68,236
746 Added 9.87%
8,307 $739,000
Q3 2021

Oct 29, 2021
SELL
$74.77 - $85.47 $13,383 - $15,299
-179 Reduced 2.31%
7,561 $584,000
Q2 2021

Aug 06, 2021
BUY
$75.51 - $84.79 $81,777 - $91,827
1,083 Added 16.27%
7,740 $646,000
Q1 2021

May 11, 2021
SELL
$74.73 - $90.69 $94,383 - $114,541
-1,263 Reduced 15.95%
6,657 $503,000
Q4 2020

Feb 12, 2021
BUY
$72.61 - $90.2 $575,071 - $714,384
7,920 New
7,920 $684,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email